Company signals · Biotech & Pharma
Vir Biotechnology
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Backdrop: a 104.6 (Hot) Talent Market Index (up 3.6 on the month) with Americas activity steady (+0.6pts).
Vir Biotechnology: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 33 tracked companies.
Signals at Vir Biotechnology
Executive hires, departures and board changes at Vir Biotechnology
Every leadership-change and senior-hiring signal observed at Vir Biotechnology, newest first, each dated and linked to the source record.
Vir Biotechnology signals in the last 90 days
1 public signal observed since 5 August 2026, by type.
More signals across Biotech & Pharma
Leadership Change · Americas
Valion Bio Inc. →Valion Bio names Thomas H. Jensen, CEO of Allarity Therapeutics, as board chair to advance Entolimod program for acute radiation syndrome following company transformation
Leadership Change · Americas
Valion Bio →Valion Bio appointed Dean Zikria as interim CEO and restructured board leadership (Thomas Jensen as chair, Sheryle Bolton stepped down). Restructuring focuses on advancing Entolimod and pursuing strategic partnerships.
Leadership Change · Americas
Flagship Pioneering →Flagship Pioneering, a scientific innovation engine, appointed two Executive Partners: Fidah Alsagoff (Head of Global Initiatives) and Maggie Sahlman (Head of Fundraising and Investor Relations).
Leadership Change · Americas
Teva Pharmaceuticals →Teva Pharmaceuticals CEO Richard Francis discusses Q2 earnings, drug pipeline, and the company's direct listing on NYSE. Signals leadership visibility and capital market transition.
Partnership · Americas
Boehringer Ingelheim →Endpoints News teaser references a collaboration between Boehringer Ingelheim and Microsoft. The excerpt is truncated and gives no terms, scope or deal size.
Capital Raising · Americas
bioAffinity Technologies, Inc. →bioAffinity Technologies raised approximately $4 million through registered direct financing and concurrent private placement priced at-the-market under Nasdaq rules.
Where Vir Biotechnology's market lands in our work
- Board Search & Advisory →
Incoming executives reshape governance needs within two quarters.
- Executive Search: Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record
- Data period
- 28 Oct 2026 – 28 Oct 2026 · 1 signals for this company
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated